Puma Biotechnology's total assets for Q2 2025 were $194.92M, a decrease of -0.64% from the previous quarter. PBYI total liabilities were $90.20M for the fiscal quarter, a -8.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.